| Ytd | -62.36% | |
| 1y | -54.03% |
| Open | 1.30 | Prev Close | 1.29 | Low | 1.27 | High | 1.37 | Mkt Cap | 2.31M |
| Vol | 185.53K | Avg Vol | 167.47K | EPS | -1.18 | P/E | -1.16 | Forward P/E | -1.49 |
| Beta | 1.38 | Short Ratio | 0.22 | Inst. Own | 2.42% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 1.18 | 200-d Avg | 2.38 | 1yr Est | 19.50 |
Total revenue increased 60% year over year to $6.4 million Net loss per share decreased 88% compared
Sonoma Pharmaceuticals Inc. (NASDAQ:SNOA) on Thursday posted a first-quarter loss of 9 cents per sha
BOULDER, CO / ACCESS Newswire / June 30, 2026 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global
Revenues increased 48% in Q4 2026 compared to Q4 2025, and 37% in FY 2026 compared to FY 2025 United
Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA - Get Free Report) was the recipient of a significant dec
US stocks mixed, Nasdaq up 100pts. Dow down 0.35%, Nasdaq up 0.56%, S&P 500 up 0.19%. Tech up 1.
BOULDER, CO / ACCESS Newswire / April 24, 2026 / Sonoma Pharmaceuticals, Inc. (the "Company" or "Son
Sonoma Pharmaceuticals jumps over 16% in after-hours trading following the U.S. retail launch of its
BOULDER, CO / ACCESS Newswire / March 24, 2026 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a globa
BOULDER, CO / ACCESS Newswire / March 18, 2026 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a globa
Revenue increased 22% for the quarter ended December 31, 2025 and 33% for the nine months ended Dece
BOULDER, CO / ACCESS Newswire / January 28, 2026 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a glo
Sonoma Pharmaceuticals (NASDAQ: SNOA - Get Free Report) and Ocular Therapeutix (NASDAQ: OCUL - Get F
Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA - Get Free Report)'s stock price passed above its two hun
BOULDER, CO / ACCESS Newswire / November 13, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a gl
BOULDER, CO / ACCESS Newswire / November 6, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a glo
Revenues increased 57% for the quarter and 38% for the six months ended September 30, 2025 compared
BOULDER, CO / ACCESS Newswire / October 14, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a glo
BOULDER, COLORADO / ACCESS Newswire / October 7, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA),
BOULDER, COLORADO / ACCESS Newswire / September 25, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA
BOULDER, CO / ACCESS Newswire / August 26, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a glob
Shares of GitLab Inc. (NASDAQ: GTLB) rose sharply in pre-market trading after the company posted be
On Friday, 497 companies set new 52-week lows.
During Friday's trading, 293 companies set new 52-week lows.
On Wednesday, 115 stocks hit new 52-week lows.
On Wednesday, 283 companies set new 52-week lows.
During Monday's session, 402 companies made new 52-week lows.
Wednesday's session saw 361 companies set new 52-week lows.
Monday saw 825 companies set new 52-week lows.
Tuesday's session saw 729 companies set new 52-week lows.
On Friday, 368 stocks hit new 52-week lows.
During Tuesday's trading, 505 companies set new 52-week lows.
Gainers Sight Sciences, Inc. (NASDAQ: SGHT) shares jumped 39.6% to settle at $33.50 on Thursday a